The Samaritan Alzheimer's Rat Model
- Mimics Human Alzheimer's
- Speeds 'Race for Time' to Find Cure
- Saves Valuable Research Money
LAS VEGAS, Oct. 1 /PRNewswire-FirstCall/ -- Samaritan Pharmaceuticals
(OTC Bulletin Board: SPHC) (http://www.samaritanpharma.com) and Taconic
Farms, Hudson, New York, are pleased to announce they have inked a
worldwide partnering agreement to commercialize "The Samaritan Alzheimer's
Rat Model." The "forgetful" rat model is a research tool used by scientists
to study the effectiveness of their new drugs to treat Alzheimer's disease.
The unique benefits of the rat model lie in its ability,
-- To mimic many features of human Alzheimer's including memory loss,
-- Speed a scientist's "race for time" in finding a cure for the
mind-robbing disease
-- Save scientists valuable research money.
(Photo: http://www.newscom.com/cgi-bin/prnh/20081001/LAW054)
The rat model is now available exclusively through Taconic. Samaritan
will receive royalties on net sales. Financial terms were not disclosed.
"Taconic is extremely pleased to offer researchers a new and
potentially invaluable weapon in the war on neurodegenerative disease,"
said Todd Little, President of Taconic. "The rapid time to disease state of
the Samaritan Alzheimer's Rat Model will enable investigators to conduct
Alzheimer's drug target screening on a much faster timeline than ever
before."
The rat model is published in Pharmacology, 2006;76:19-33
"Taconic provides us with an experienced partner to monetize this
unique animal model to 'rat out' Alzheimer's. The rat model is
groundbreaking, in that it offers significant advantages over other options
previously available for the study of Alzheimer's. We anticipate Taconic
achieving and surpassing projected market penetrations in international
markets," said Dr. Greeson, CEO, Samaritan Pharmaceuticals.
Samaritan's Phase I, Alzheimer's drug Caprospinol (SP-233), utilized
"The Samaritan Alzheimer's Rat Model." and the Morris Water Maze, in an IND
enabling, proof of concept study. Treated rats demonstrated Caprospinol's
efficacy by,
-- clearing beta-amyloid plaque formation
-- restoring the memory of tested rats
-- protecting mitochondria function
-- protecting cell viability
-- decreasing cell death
Samaritan Pharmaceuticals: "Transforming Today's Science Into
Tomorrow's Cures."
Samaritan Pharmaceuticals is a biopharmaceutical company committed to
bringing innovative life-saving drugs to suffering patients. Samaritan
website: http://www.samaritanpharma.com. Please register for upcoming
conference calls, news, and events.
Taconic Farms, Inc.
Taconic was founded in 1952 as a family-owned business in New York's
Hudson River Valley. Since then, the company has become one of the largest
laboratory rodent providers in the world with a reputation for consistently
producing high quality, well-defined rats and mice. Taconic has six
breeding facilities and three service laboratories in the USA and Europe, a
staff of over 900, and a commitment to technological innovation. Taconic
website, http://www.taconic.com
Disclaimer
The company disclaims any information created by an outside party and
endorses only information communicated by its press releases, filings, and
website. This news release contains forward-looking statements that reflect
management's current beliefs about the potential for its drug candidates,
science, and technology. For additional information about the factors that
affect the company's business, please read the company's latest Form 10-K
filed April 14, 2008. The company undertakes no duty to update
forward-looking statements.
Samaritan Pharma Contact: Barrie Fuller 702-735-7001
barriefuller@samaritanpharma.com
SOURCE Samaritan Pharmaceuticals
 back to top
Related links:
http://www.samaritanpharma.com
http://www.taconic.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20081001/LAW054
PRN Photo Desk, photodesk@prnewswire.com
http://www.prnewswire.com/comp/158311.html/
CONTACT:
Barrie Fuller of Samaritan Pharmaceuticals,
+1-702-735-7001, barriefuller@samaritanpharma.com
|
